# Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

> **NCT00782587** · PHASE1 · COMPLETED · sponsor: **Halozyme Therapeutics** · enrollment: 14 (actual)

## Conditions studied

- Superficial Bladder Cancer

## Interventions

- **DRUG:** Chemophase

## Key facts

- **NCT ID:** NCT00782587
- **Lead sponsor:** Halozyme Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2010-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782587, "Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00782587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*